Skip to main content
. 2022 Mar 22;227(4):498–511. doi: 10.1093/infdis/jiac098

Table 2.

Respiratory Virus Detections Among Case Patients Included in the Analysis

Respiratory Virus Detected All LRTI and Pneumonia Cases Analyzed, No. (%) (N = 17 416)a
LRTI and Pneumonia Cases by Clinical Syndrome, No. (%) LRTI and Pneumonia Cases by Patient’s Hospitalization Status, No (%)
Nonpneumonia LRTI (n = 4644) Pneumonia (n = 12 772) Not Hospitalized (n = 7634) Hospitalized (n = 9782)
Any virus detected, by specific virus identified
 Influenza A 3956 (22.7) 1974 (42.5) 1982 (15.5) 1905 (25.0) 2051 (21.0)
 Influenza B 1141 (6.6) 607 (13.1) 534 (4.2) 588 (7.7) 553 (5.7)
 RSV 1462 (8.4) 320 (6.9) 1142 (8.9) 562 (7.4) 900 (9.2)
  HCoVs (229E, HKU1, OC43, NL63) 975 (5.6) 204 (4.4) 771 (6.0) 416 (5.4) 559 (5.7)
 Parainfluenza viruses (1–4) 1259 (7.2) 328 (7.1) 931 (7.3) 539 (7.1) 720 (7.4)
 Adenoviruses 172 (1.0) 37 (0.8) 135 (1.1) 80 (1.0) 92 (0.9)
 HMPV 1460 (8.4) 184 (4.0) 1276 (10.0) 602 (7.9) 858 (8.8)
 Enteroviruses 3431 (19.7) 643 (13.8) 2788 (21.8) 1533 (20.1) 1898 (19.4)
 Any respiratory virus 13 856 (79.6) 4297 (92.5) 9559 (74.8) 6225 (81.5) 7631 (78.0)
Single virus detected
 Influenza A 3693 (21.2) 1859 (40.0) 1834 (14.4) 1793 (23.5) 1900 (19.4)
 Influenza B 1030 (5.9) 557 (12.0) 473 (3.7) 546 (7.2) 484 (4.9)
 RSV 1283 (7.4) 284 (6.1) 999 (7.8) 504 (6.6) 779 (8.0)
 HCoVs (229E, HKU1, OC43, NL63) 743 (4.3) 125 (2.7) 618 (4.8) 314 (4.1) 429 (4.4)
 Parainfluenza viruses (1–4) 1174 (6.7) 305 (6.6) 869 (6.8) 504 (6.6) 670 (6.8)
 Adenoviruses 128 (0.7) 24 (0.5) 104 (0.8) 60 (0.8) 68 (0.7)
 HMPV 1353 (7.8) 171 (3.7) 1182 (9.3) 564 (7.4) 789 (8.1)
 Enteroviruses 3149 (18.1) 572 (12.3) 2577 (20.2) 1412 (18.5) 1737 (17.8)
No virus detected (negative for all)b 3560 (20.4) 347 (7.5) 3213 (25.2) 1409 (18.5) 2151 (22.0)

Abbreviations: HCoVs, human coronaviruses; HMPV, human metapneumovirus; LRTI, lower respiratory tract infection; RSV, respiratory syncytial virus.

Totals do not necessarily reflect the true prevalence of each virus (or no viruses) among case patients, as we drew a 20% sample of virus-negative case patients. For LRTIs, diagnosis codes from the International Classification of Diseases, Tenth Revision, Clinical Modification, are provided in Supplementary Table 1).

We analyzed data from a randomly sampled subset of all virus-negative case patients.